The Protean Role of Health Care Delivery Organizations in Comparative Effectiveness Research
Authors:
- Andrew L. MasicaAMAndrew L. Masica
- David J. BallardDBDavid J. Ballard
- 1 December 2009
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 84 (12) , 1062-1064
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed PopulationMayo Clinic Proceedings, 2009
- Guideline-Concordant Therapy and Reduced Mortality and Length of Stay in Adults With Community-Acquired PneumoniaArchives of internal medicine (1960), 2009
- The Shifting Mission of Health Care Delivery OrganizationsNew England Journal of Medicine, 2009
- Implementing a Standardized Order Set for Community-Acquired Pneumonia: Impact on Mortality and CostThe Joint Commission Journal on Quality and Patient Safety, 2009
- Comparative Effectiveness — Thinking beyond Medication A versus Medication BNew England Journal of Medicine, 2009
- Comparative-Effectiveness Research — Implications of the Federal Coordinating Council's ReportNew England Journal of Medicine, 2009
- The Neglected Purpose of Comparative-Effectiveness ResearchNew England Journal of Medicine, 2009
- The “3T’s” Road Map to Transform US Health CareJAMA, 2008
- Eulogy for a Quality MeasureNew England Journal of Medicine, 2007